The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Mechanisms of sarcoma development
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
The retinoblastoma protein and cell cycle control
Weinberg, R. A. (1995) · Cell · doi:10.1016/0092-8674(95)90385-2 · Cited by 4,862
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649
Germ Line p53 Mutations in a Familial Syndrome of Breast Cancer, Sarcomas, and Other Neoplasms
Malkin, D., Li, F. P., Strong, L. C., Fraumeni, J. F., Nelson, C. E., Kim, D. H., Kassel, J., Gryka, M. A., Bischoff, F. Z., Tainsky, M. A., et al. (1990) · Science · doi:10.1126/science.1978757 · Cited by 3,765
Jemal, A., Murray, T., Samuels, A., Ghafoor, A., Ward, E., & Thun, M. J. (2003) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.53.1.5 · Cited by 3,275
PDGFRA Activating Mutations in Gastrointestinal Stromal Tumors
Heinrich, M. C., Corless, C. L., Duensing, A., McGreevey, L., Chen, C.-J., Joseph, N., Singer, S., Griffith, D. J., Haley, A., Town, A., et al. (2003) · Science · doi:10.1126/science.1079666 · Cited by 2,301
Pinkel, D., Segraves, R., Sudar, D., Clark, S., Poole, I., Kowbel, D., Collins, C., Kuo, W.-L., Chen, C., Zhai, Y., et al. (1998) · Nature Genetics · doi:10.1038/2524 · Cited by 2,240
The complexity of p53 modulation: emerging patterns from divergent signals
Giaccia, A. J., & Kastan, M. B. (1998) · Genes & Development · doi:10.1101/gad.12.19.2973 · Cited by 1,314
van Oosterom, A. T., Judson, I., Verweij, J., Stroobants, S., di Paola, E. D., Dimitrijevic, S., Martens, M., Webb, A., Sciot, R., Van Glabbeke, M., et al. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06535-7 · Cited by 1,264
KIT activation is a ubiquitous feature of gastrointestinal stromal tumors.
Rubin, B. P., Singer, S., Tsao, C., Duensing, A. U., Lux, M. L., Ruiz, R., Hibbard, M. K., Chen, C. J., Xiao, S., Tuveson, D. A., et al. (2001) · PubMed · Cited by 959
Sorensen, P. H. B., Lynch, J. C., Qualman, S. J., Tirabosco, R., Lim, J. F., Maurer, H. M., Bridge, J. A., Crist, W. M., Triche, T. J., & Barr, F. G. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.03.137 · Cited by 742
Druker, B. J., & Lydon, N. B. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9083 · Cited by 707
Familial gastrointestinal stromal tumours with germline mutation of the KIT gene
Nishida, T., Hirota, S., Taniguchi, M., Hashimoto, K., Isozaki, K., Nakamura, H., Kanakura, Y., Tanaka, T., Takabayashi, A., Matsuda, H., et al. (1998) · Nature Genetics · doi:10.1038/1209 · Cited by 586
Molecular characterisation of soft tissue tumours: a gene expression study
Nielsen, T. O., West, R. B., Linn, S. C., Alter, O., Knowling, M. A., O'Connell, J. X., Zhu, S., Fero, M., Sherlock, G., Pollack, J. R., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08270-3 · Cited by 576
Leukemia in twins: lessons in natural history
Greaves, M. F., Maia, A. T., Wiemels, J. L., & Ford, A. M. (2003) · Blood · doi:10.1182/blood-2002-12-3817 · Cited by 543
Spontaneous and carcinogen-induced tumorigenesis in p53-deficient mice.
Harvey, M., McArthur, M. J., Montgomery, C. A., Butel, J. S., Bradley, A., & Donehower, L. A. (1993) · Nature Genetics · doi:10.1038/ng1193-225 · Cited by 542
Ladanyi, M., Antonescu, C. R., Leung, D. H. Y., Woodruff, J. M., Kawai, A., Healey, J. H., Brennan, M. F., Bridge, J. A., Neff, J. R., Barr, F. G., et al. (2002) · PubMed · Cited by 536
Simon, M.-P., Pedeutour, F., Sirvent, N., Grosgeorge, J., Minoletti, F., Coindre, J.-M., Terrier-Lacombe, M.-J., Mandahl, N., Craver, R., Blin, N., et al. (1997) · Nature Genetics · doi:10.1038/ng0197-95 · Cited by 535
p53 Mutation and MDM2 amplification in human soft tissue sarcomas.
Leach, F. S., Tokino, T., Meltzer, P. S., Burrell, M., Oliner, J., Smith, S., HILL, D. E., Sidransky, D., Kinzler, K. W., & Vogelstein, B. (1993) · PubMed · Cited by 533
Self-citationIssues and progress with protein kinase inhibitors for cancer treatment
Dancey, J., & Sausville, E. A. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1066 · Cited by 526
EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma.
de Alava, E., Kawai, A., Healey, J. H., Fligman, I., Meyers, P. A., Huvos, A. G., Gerald, W. L., Jhanwar, S. C., Argani, P., Antonescu, C. R., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.4.1248 · Cited by 524
Cancer Incidence After Retinoblastoma: Radiation Dose and Sarcoma Risk
Wong, F. L. (1997) · JAMA · doi:10.1001/jama.1997.03550150066037 · Cited by 486
Gene expression profiling of alveolar rhabdomyosarcoma with cDNA microarrays.
Khan, J. I., Simon, R., Bittner, M. L., Chen, Y., Leighton, S. B., Pohida, T. J., Smith, P. D., Jiang, Y. Y., Gooden, G. C., Trent, J. M., et al. (1998) · PubMed · Cited by 437
Self-citationSecond Nonocular Tumors in Retinoblastoma Survivors
Abramson, D. H., Ellsworth, R. M., Kitchin, F. D., & Tung, G. (1984) · Ophthalmology · doi:10.1016/s0161-6420(84)34127-6 · Cited by 436
Knezevich, S. R., Garnett, M. J., Pysher, T. J., Beckwith, J. B., Grundy, P. E., & Sorensen, P. H. B. (1998) · PubMed · Cited by 412
Rhabdomyosarcoma in Children: Epidemiologic Study and Identification of a Familial Caneer Syndrome
(1969) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/43.6.1365 · Cited by 397
Rubin, B. P., Schuetze, S. M., Eary, J. F., Norwood, T. H., Mirza, S. K., Conrad, E. U., & Bruckner, J. D. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.01.027 · Cited by 364
(1999) · PubMed · Cited by 338
Barone, M. V., Crozat, A., Tabaee, A., Philipson, L., & Ron, D. (1994) · Genes & Development · doi:10.1101/gad.8.4.453 · Cited by 336
Khan, J., Bittner, M. L., Saal, L. H., Teichmann, U., Azorsa, D. O., Gooden, G. C., Pavan, W. J., Trent, J. M., & Meltzer, P. S. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.23.13264 · Cited by 314
Self-citationImmunohistochemical Staining for KIT (CD117) in Soft Tissue Sarcomas Is Very Limited in Distribution
Hornick, J. L., & Fletcher, C. D. M. (2002) · American Journal of Clinical Pathology · doi:10.1309/lx9u-f7p0-uwdh-8y6r · Cited by 306
Fredericks, W. J., Galili, N., Mukhopadhyay, S., Rovera, G., Bennicelli, J., Barr, F. G., & Rauscher, F. J. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.3.1522 · Cited by 305
Shimizu, A., O'Brien, K. P., Sjöblom, T., et al. (1999) · PubMed · Cited by 289
Gastrointestinal stromal tumor workshop
Berman, J. J., & O’Leary, T. J. (2001) · Human Pathology · doi:10.1053/hupa.2001.25484 · Cited by 273
Rhabdomyosarcoma – working out the pathways
Merlino, G., & Helman, L. J. (1999) · Oncogene · doi:10.1038/sj.onc.1203038 · Cited by 271
Self-citationLessnick, S. L., Dacwag, C. S., & Golub, T. R. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00056-9 · Cited by 264
A model for embryonal rhabdomyosarcoma tumorigenesis that involves genome imprinting.
Scrable, H., Cavenee, W., Ghavimi, F., Lovell, M., Morgan, K., & Sapienza, C. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.19.7480 · Cited by 261
El‐Badry, O. M., Minniti, C. P., Kohn, E. C., Houghton, P. J., Daughaday, W. H., & Helman, L. J. (1990) · PubMed · Cited by 249
Self-citationMalignant peripheral nerve sheath tumors in neurofibromatosis 1
King, A. A., Debaun, M. R., Riccardi, V. M., & Gutmann, D. H. (2000) · American Journal of Medical Genetics · doi:10.1002/1096-8628(20000828)93:5<388::aid-ajmg8>3.0.co;2-# · Cited by 246
Patched Target Igf2 Is Indispensable for the Formation of Medulloblastoma and Rhabdomyosarcoma
Hahn, H., Wojnowski, L., Specht, K., Kappler, R., Calzada-Wack, J., Potter, D., Zimmer, A., Müller, U., Samson, E., Quintanilla-Martinez, L., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000352200 · Cited by 233
Expression Profiling of Synovial Sarcoma by cDNA Microarrays
Allander, S. V., Illei, P. B., Chen, Y., Antonescu, C. R., Bittner, M., Ladanyi, M., & Meltzer, P. S. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64437-9 · Cited by 186
Self-citationAllander, S. V., Nupponen, N. N., Ringnér, M., Hostetter, G. H., Maher, G. W., Goldberger, N. E., Chen, Y., Carpten, J. D., Elkahloun, A. G., & Meltzer, P. S. (2001) · PubMed · Cited by 182
Self-citationThe EWS-WT1 translocation product induces PDGFA in desmoplastic small round-cell tumour
Lee, S. B., Kolquist, K. A., Nichols, K., Englert, C., Maheswaran, S., Ladanyi, M., Gerald, W. L., & Haber, D. A. (1997) · Nature Genetics · doi:10.1038/ng1197-309 · Cited by 180
Stratton, M. R., Moss, S., Warren, W., Patterson, H., Clark, J. A., Fisher, C., Fletcher, C., Ball, A., Thomas, M., & Gusterson, B. A. (1990) · PubMed · Cited by 177
Sharpless, N. E., Ferguson, D. O., O'Hagan, R. C., Castrillon, D. H., Lee, C., Farazi, P. A., Alson, S., Fleming, J., Morton, C. C., Frank, K., et al. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00425-7 · Cited by 175
Fritz, B., Schubert, F., Wrobel, G., Schwäenen, C., Weßendorf, S., Neßling, M., Korz, C., Rieker, R. J., Montgomery, K. T., Kucherlapati, R., et al. (2002) · PubMed · Cited by 162
Prognostic impact of P53 status in Ewing sarcoma
de Álava, E., Antonescu, C. R., Panizo, Á., Leung, D. H. Y., Meyers, P. A., Huvos, A. G., Pardo-Mind�n, F. J., Healey, J. H., & Ladanyi, M. (2000) · Cancer · Cited by 159
Synergism between INK4a/ARF inactivation and aberrant HGF/SF signaling in rhabdomyosarcomagenesis
Sharp, R., Recio, J. A., Jhappan, C., Otsuka, T., Liu, S., Yu, Y., Liu, W., Anver, M., Navid, F., Helman, L. J., et al. (2002) · Nature Medicine · doi:10.1038/nm787 · Cited by 158
Self-citationGenome-wide analysis of gene expression in synovial sarcomas using a cDNA microarray.
Nagayama, S., Katagiri, T., Tsunoda, T., Hosaka, T., Nakashima, Y., Araki, N., Kusuzaki, K., Nakayama, T., Tsuboyama, T., Nakamura, T., et al. (2002) · PubMed · Cited by 157
Lin, P. P., Brody, R., Hamelin, A. C., Bradner, J. E., Healey, J. H., & Ladanyi, M. (1999) · PubMed · Cited by 148
The Splicing Factor U1C Represses EWS/FLI-mediated Transactivation
Knoop, L. L., & Baker, S. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001661200 · Cited by 133
Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors
Sandberg, A. A., & Bridge, J. A. (2003) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(02)00848-8 · Cited by 130
Bennicelli, J. L., Edwards, R. H., & Barr, F. G. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.11.5455 · Cited by 128
Ferracini, R., Olivero, M., Renzo, M. F. D., Martano, M., Giovanni, C. D., Nanni, P., Basso, G., Scotlandi, K., Lollini, P., & Comoglio, P. M. (1996) · PubMed · Cited by 122
Sjögren, H., Meis‐Kindblom, J. M., Örndal, C., Bergh, P., Ptaszyński, K., Åman, P., Kindblom, L., & Stenman, G. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63875-8 · Cited by 114
McGary, E. C., WEBER, K. L., Mills, L., Doucet, M., Lewis, V., Lev, D. C., Fidler, I. J., & Bar‐Eli, M. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-1101 · Cited by 113
Prognostic impact of INK4A deletion in Ewing sarcoma
Guo, W., Antonescu, C. R., de Álava, E., Leung, D. H. Y., Huvos, A. G., Meyers, P. A., Healey, J. H., & Ladanyi, M. (2000) · Cancer · Cited by 111
EWS/FLI Alters 5′-Splice Site Selection
Knoop, L. L., & Baker, S. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008950200 · Cited by 110
Tumor suppressor genes and related molecules in leiomyosarcoma.
Tos, A. P. D., Maestro, R., Doglioni, C., Piccinin, S., Libera, D. D., Boiocchi, M., & Fletcher, C. D. �. (1996) · Europe PMC (PubMed Central) · Cited by 105
Pax3-FKHR Knock-In Mice Show Developmental Aberrations but Do Not Develop Tumors
Lagutina, I. V., Conway, S. J., Sublett, J. E., & Grosveld, G. C. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.20.7204-7216.2002 · Cited by 78
PIM3 Proto-Oncogene Kinase Is a Common Transcriptional Target of Divergent EWS/ETS Oncoproteins
Deneen, B., Welford, S. M., Ho, T., Hernandez, F., Kurland, I. J., & Denny, C. T. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.11.3897-3908.2003 · Cited by 77
Adelmant, G., Gilbert, J. D., & Freytag, S. O. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.25.15574 · Cited by 75
Insulin-like growth factor II and PAX3-FKHR cooperate in the oncogenesis of rhabdomyosarcoma.
Wang, W., Kumar, P., Wang, W., Epstein, J. A., Helman, L. J., Moore, J., & Kumar, S. (1998) · PubMed · Cited by 72
Self-citationBarber, T. D., Barber, M. C., Tomescu, O. A., Barr, F. G., Ruben, S. M., & Friedman, T. B. (2002) · Genomics · doi:10.1006/geno.2002.6703 · Cited by 72
Zhang, L., & Wang, C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205424200 · Cited by 57
Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors. Mesothelioma
Sandberg, A. A., & Bridge, J. A. (2001) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(01)00432-0 · Cited by 55
Mutation of the p53 gene in postradiation sarcoma.
Nakanishi, H., Tomita, Y., Myoui, A., Yoshikawa, H., Sakai, K., Kato, Y., Ochi, T., & Aozasa, K. (1998) · PubMed · Cited by 47
RNA splicing mediated by YB‐1 is inhibited by TLS/CHOP in human myxoid liposarcoma cells
Rapp, T. B., Yang, L., Conrad, E. U., Mandahl, N., & Chansky, H. A. (2002) · Journal of Orthopaedic Research® · doi:10.1016/s0736-0266(02)00006-2 · Cited by 37
Reduced growth of human sarcoma xenografts in hosts homozygous for the lit mutation
Deitel, K., Dantzer, D., Ferguson, P. C., et al. (2002) · Journal of Surgical Oncology · doi:10.1002/jso.10136 · Cited by 35
Angiosarcoma and hepatocellular carcinoma in vinyl chloride workers
EVANS, D. M. D., WILLIAMS, W. J., & Kung, I. T. M. (1983) · Histopathology · doi:10.1111/j.1365-2559.1983.tb02251.x · Cited by 34
Expression of the FUS domain restores liposarcoma development in CHOP transgenic mice
Pérez-Mancera, P. A., Pérez‐Losada, J., Sánchez‐Martín, M., Rodríguez-García, M. A., Flores, T., Battaner, E., Gutiérrez‐Adán, A., Pintado, B., & Sánchez-García, I. (2002) · Oncogene · doi:10.1038/sj.onc.1205220 · Cited by 31
Cited by
B cells are associated with survival and immunotherapy response in sarcoma
Petitprez, F., de Reyniès, A., Keung, E. Z., Chen, T. W.-W., Sun, C.-M., Calderaro, J., Jeng, Y.-M., Hsiao, L.-P., Lacroix, L., Bougoüin, A., et al. (2020) · Nature · doi:10.1038/s41586-019-1906-8 · Cited by 1,942
Spontaneous Human Adult Stem Cell Transformation
Rubio, D., Garcia-Castro, J., Martín, M. C., de la Fuente, R., Cigudosa, J. C., Lloyd, A. C., & Bernad, A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4194 · Cited by 1,036
RetractedDescriptive epidemiology of sarcomas in Europe: Report from the RARECARE project
Stiller, C. A., Trama, A., Serraino, D., Rossi, S., Navarro, C., Chirlaque, M. D., & Casali, P. G. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2012.09.011 · Cited by 683
Perry, J. A., Kiezun, A., Tonzi, P., Van Allen, E. M., Carter, S. L., Baca, S. C., Cowley, G. S., Bhatt, A. S., Rheinbay, E., Pedamallu, C. S., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1419260111 · Cited by 481
Descriptive epidemiology of Kaposi sarcoma in Europe. Report from the RARECARE project
Stiller, C. A., Trama, A., Brewster, D. H., Verne, J., Bouchardy, C., Navarro, C., Chirlaque, M. D., Marcos-Gragera, R., Visser, O., Serraino, D., et al. (2014) · Cancer Epidemiology · doi:10.1016/j.canep.2014.09.009 · Cited by 463
Metadata
- Authors
- Helman, L. J., & Meltzer, P.
- Venue
- Nature Reviews Cancer
- Published
- 2003-09-01
- Volume
- 3
- Issue
- 9
- Pages
- 685-694
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2068923084
- Cited by
- 460
- References
- 71
- FWCI
- 2.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.